Anzeige
❌
Mehr »
Samstag, 14.11.2026 - Börsentäglich über 12.000 News
90 Millionen C$ Umsatz: Der größte Teil davon kommt jedes Jahr wieder
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SS

WKN: A2P46G | ISIN: SE0014428512 | Ticker: 4P41
Xetra
13.11.26 | 13:17
5,095 Euro
-7,28 % -0,400
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SURGICAL SCIENCE SWEDEN AB Chart 1 Jahr
5-Tage-Chart
SURGICAL SCIENCE SWEDEN AB 5-Tage-Chart
RealtimeGeldBriefZeit
4,9845,17513.11.
5,0305,16013.11.

Aktuelle News zur SURGICAL SCIENCE SWEDEN Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSurgical Science Q3 2026 slides: profitability hits target amid flat sales4
DoSurgical Science Sweden AB GAAP EPS of SEK 0.67, revenue of SEK 260.2M4
DoSurgical Science Sweden AB Reports Increase In Q3 Bottom Line4
19.10.XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.202614.043Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen. 1. US88025U1097 10X GENOMICS INC 2. NL0000852564 AALBERTS NV 3. SE0016589188 ELECTROLUX AB 4. SE0000115446...
► Artikel lesen
19.08.Surgical Science Q2 2026 slides: margin target met, license sales surge11
19.08.Surgical Science Sweden AB GAAP EPS of SEK 0.41, revenue of SEK 254.5M3
SURGICAL SCIENCE SWEDEN Aktie jetzt für 0€ handeln
19.08.Surgical Science Sweden AB: Interim report January-June 2026: Strong license revenue and improved profitability442Second quarter 2026 (April-June)Net sales amounted to SEK 254.5 (209.2) million, an increase of 22 percent compared with the corresponding period in the preceding year. Calculated in local currencies...
► Artikel lesen
21.05.Surgical Science Sweden AB: Report from the Annual General Meeting of Surgical Science Sweden AB (publ)446At Surgical Science Sweden AB (publ)'s Annual General Meeting today, the following, amongst other things, was decided: To adopt the company's and the group's income statements and balance sheets for...
► Artikel lesen
20.05.Surgical Science Sweden AB Bottom Line Retreats In Q19
20.05.Surgical Science Sweden AB: Interim report January - March 2026: A solid start to the year586First quarter 2025 (Jan-Mar) Net sales amounted to SEK 235.5 (250.7) million, a decrease of 6 percent compared with the corresponding period in the preceding year. Calculated in local currencies, sales...
► Artikel lesen
25.04.Globaler Mega-Deal: Bioxyne und Aurora Cannabis könnten den Markt umkrempeln!
19.02.Surgical Science Sweden AB: Year-end report 2025: Profitability in line with financial targets734Fourth quarter 2025 (October - December)Net sales amounted to SEK 268.9 (251.5) million, an increase of 7 percent compared with the corresponding period in the preceding year. Calculated in local currencies...
► Artikel lesen
08.12.25Surgical Science Sweden AB: Surgical Science announces new financial targets and initiates the process of a listing transfer779Surgical Science today communicates new financial targets. Growth shall amount to 10-15% annually with an adjusted EBIT of at least 15%. The company estimates that the targets will be met in 2027. As...
► Artikel lesen
25.11.25Surgical Science Sweden AB: Intuitive cancels the MoU and reverts to existing agreements. Surgical Science estimates that this will have a negative impact on license revenues of around SEK 60-90 million in 2026, compared to 20251.603The Memorandum of Understanding (MoU) signed between the companies on January 15 this year did not turn into a signed legal agreement. As a consequence of this, Surgical Science will not reach the previously...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1